Upregulation of AGR2 is associated with the initiation of cancer, and this protein can induce cell apoptosis and enhance the sensitivity of pancreatic cancer cells to chemotherapy via the extracellular signal‐regulated kinase (ERK)/serine-threonine kinase (AKT) pathways [25]. Here, AGR2 is linked to familial pancreatic carcinoma.